ShareHope Medicine Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 11, 2022 at 06:54 pm EST
Share
ShareHope Medicine Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 1,055.26 million compared to TWD 939.76 million a year ago. Net income was TWD 114.07 million compared to TWD 41.59 million a year ago. Basic earnings per share from continuing operations was TWD 0.9048 compared to TWD 0.3333 a year ago. Diluted earnings per share from continuing operations was TWD 0.8952 compared to TWD 0.3238 a year ago.
For the nine months, sales was TWD 3,211.51 million compared to TWD 2,783.99 million a year ago. Net income was TWD 333.3 million compared to TWD 133.25 million a year ago. Basic earnings per share from continuing operations was TWD 2.6476 compared to TWD 1.0571 a year ago. Diluted earnings per share from continuing operations was TWD 2.619 compared to TWD 1.0476 a year ago.
ShareHope Medicine Co., Ltd. is principally engaged in the supply of pharmaceuticals, medical materials and technology materials. The Company is also engaged in the provision of medical health check and medical testing laboratories management consulting and entrusted operation services, the leasing of equipment and the provision of long-term care services. The Company operates its business through five segments: pharmaceutical distribution, health management, technology materials, hospitals and others. The Company distributes its products within domestic market and to overseas markets.
SHAREHOPE MEDICINE CO., LTD. 
